4-(3-Bromoimidazo[1,2-b]Pyridazin-6-Yl)Morpholine

4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine has potential applications in drug discovery and development due to its kinase inhibition properties. It may serve as a lead compound for developing new therapeutics targeting TAK1-related pathways. Additionally, its unique structural features make it suitable for studies in structure-activity relationship (SAR) analyses aimed at optimizing potency and selectivity against various kinases.

Research indicates that 4-(3-Bromoimidazo[1,2-b]pyridazin-6-yl)morpholine exhibits significant biological activity as an inhibitor of the TAK1 kinase. In studies, it has shown promising results in inhibiting TAK1 with an efficacy of up to 95% at certain concentrations, making it a candidate for further development as a therapeutic agent against diseases where TAK1 plays a pivotal role, such as cancer and inflammatory disorders.

Please email your required order quantity and detailed technical specifications to sales@.
Our sales team will promptly prepare an accurate quotation for your bulk order and provide a comprehensive pricing proposal.

All products are for research and development use only, not for any other uses, and must be handled by technically-qualified persons.

These products are explicitly not intended to be used in foods and/or cosmetics and/or drugs (human and veterinary) and/or consumer products and/or biocides and/or pesticides of any kind unless explicitly stated otherwise.

Products are not sold to individuals. We do not ship to residential addresses. Consumer orders will be cancelled without notice.

New customers undergo an internal onboarding process. As part of this process, new customers may be asked for more information. Additional restrictions may apply.